(XLSX 10 KB) Additional file 3: Table S3: Selleckchem LY2835219 distribution of telomeric gene expression among the 40 HCC and the 12 non-cirrhotic liver samples. (XLSX 50 KB) Additional file 4: Table S4: Cause-specific distribution of telomere genes expression among the 28 cirrhotic liver samples. (XLSX 36 KB) Additional file 5: Table S5: Cause-specific distribution of telomere genes expression Evofosfamide in vitro among the 40 HCC samples. (XLSX 27 KB) References 1. McGlynn KA,

London WT: The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 2011, 15:223–243. vii-xPubMedCrossRef 2. Li R, Qian N, Tao K, You N, Wang X, Dou K: MicroRNAs involved in neoplastic transformation of liver cancer stem cells. J Exp Clin Cancer Res 2010, 29:169.PubMedCrossRef 3. Begus-Nahrmann Y, Hartmann D, Kraus J, Eshraghi

P, Scheffold A, Grieb M, Rasche V, Schirmacher P, Lee HW, Kestler HA, et al.: Transient telomere dysfunction induces STAT inhibitor chromosomal instability and promotes carcinogenesis. J Clin Invest 2012, 122:2283–2288.PubMedCrossRef 4. Farazi PA, Glickman J, Horner J, Depinho RA: Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression. Cancer Res 2006, 66:4766–4773.PubMedCrossRef 5. Farazi PA, Glickman J, Jiang S, Yu A, Rudolph KL, DePinho RA: Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer SB-3CT Res 2003, 63:5021–5027.PubMed 6. Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka S, Manns MP, Rudolph KL: Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Hepatology 2004, 40:80–86.PubMedCrossRef 7. Plentz RR, Park YN, Lechel A, Kim H, Nellessen F, Langkopf BH, Wilkens L, Destro A, Fiamengo B, Manns MP,

et al.: Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 2007, 45:968–976.PubMedCrossRef 8. Plentz RR, Schlegelberger B, Flemming P, Gebel M, Kreipe H, Manns MP, Rudolph KL, Wilkens L: Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma. Hepatology 2005, 42:522–526.PubMedCrossRef 9. Lai XF, Shen CX, Wen Z, Qian YH, Yu CS, Wang JQ, Zhong PN, Wang HL: PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells. J Exp Clin Cancer Res 2012, 31:12.PubMedCrossRef 10. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349–352.PubMedCrossRef 11. De Lange T: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005, 19:2100–2110.PubMedCrossRef 12. Gilson E, Geli V: How telomeres are replicated. Nat Rev Mol Cell Biol 2007, 8:825–838.PubMedCrossRef 13.